These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [On the use of thioproperazine in schizophrenia]. Chanoit P; Mollier-Vallée A; Morgenstern B Encephale; 1969; 58(2):112-57. PubMed ID: 4393276 [No Abstract] [Full Text] [Related]
25. Clinical pharmacological studies with haloperidol. Dunlop E J New Drugs; 1966; 6(4):243-6. PubMed ID: 5968054 [No Abstract] [Full Text] [Related]
26. [A therapeutic pathomorphosis of schizophrenia proceeding with paranoid disorders]. Ozola MIa Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(4):600-5. PubMed ID: 5497116 [No Abstract] [Full Text] [Related]
27. Schizophrenic and paranoid disorders in the aged. Varner RV; Gaitz CM Psychiatr Clin North Am; 1982 Apr; 5(1):107-18. PubMed ID: 6124954 [No Abstract] [Full Text] [Related]
29. [Atropinic comas and their therapeutic value]. Bilikiewicz T Ann Med Psychol (Paris); 1969 Jun; 2(1):1-13. PubMed ID: 5387480 [No Abstract] [Full Text] [Related]
30. Comparison of the therapeutic results of clothiapin and perphenazine in schizophrenia. Rodová A; Náhunek K; Svestka J Act Nerv Super (Praha); 1971; 13(3):171-3. PubMed ID: 4939829 [No Abstract] [Full Text] [Related]
31. [Experiences with depot-neuroleptics in an after-care unit. Organization of the therapy exemplified with pipotiazine palmitate]. Salvesen C; Vaksdal K Tidsskr Nor Laegeforen; 1973 Aug; 93(24):1699-703. PubMed ID: 4149082 [No Abstract] [Full Text] [Related]
32. [Effect of patient's attitude toward treatment on the outcome of psychopharmacotherapy]. Bogacka I Psychiatr Pol; 1969; 3(6):671-4. PubMed ID: 5367109 [No Abstract] [Full Text] [Related]
33. [Clinical treatment of chronic psychoses with flupenthixol-decanoate (Fluanxol-Depot)]. Gross H; Kaltenbäck E Wien Klin Wochenschr; 1972 Feb; 84(5):80-4. PubMed ID: 5015880 [No Abstract] [Full Text] [Related]
34. [Several atypical indications of therapy of lithium]. Dreyfuss L; Lauras A; Hanon E; Housse J Ann Med Psychol (Paris); 1974 Nov; 2(4):585-99. PubMed ID: 4458588 [No Abstract] [Full Text] [Related]
35. [Results of treatment of schizophrenic psychoses with neuroleptics combined with subcomatic insulin]. Majewski J; Stempurska K Psychiatr Pol; 1968; 2(1):37-42. PubMed ID: 4875961 [No Abstract] [Full Text] [Related]
36. Central effects of metronidazole. Itil TM; Holden JM; Keskiner A; Shapiro D Psychiatr Res Rep Am Psychiatr Assoc; 1968 Mar; 24():148-65. PubMed ID: 4888685 [No Abstract] [Full Text] [Related]
37. [Study on the action of stelazine on t0ehigher nervous activity of schizophrenics]. Zakharova NN Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(1):98-103. PubMed ID: 5651468 [No Abstract] [Full Text] [Related]
38. [Treatment of schizophrenic patients with triperidol (trisedil)]. Ezhkov AA Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(9):1394-400. PubMed ID: 5705722 [No Abstract] [Full Text] [Related]
39. [Experience with the butyrophenone preparation Luvatren in the therapy of schizophrenia]. Weiser G Wien Med Wochenschr; 1968 May; 118(19):444-6. PubMed ID: 5702494 [No Abstract] [Full Text] [Related]
40. [Experiences with depot form flupenthixol]. Bruck J; Guss H Wien Med Wochenschr; 1971 Feb; 121(7):110-2. PubMed ID: 5545657 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]